# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001004726-26-000801
**Filing Date:** 2026-2
**Character Count:** 25379
**Document Hash:** be3e6faffcf5e6f0c01da9786e5c9322
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001004726-26-000801.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0001004726-26-000801

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663

**ORGANIZATION NAME:**
- **EIN:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 26663861

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares U.S. Pharmaceuticals ETF (Series ID: S000009417)

| Class ID   | Class Name                       | Ticker Symbol   |
|:---|:---|:---|
| C000025771 | iShares U.S. Pharmaceuticals ETF | IHE             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares U.S. Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000009417

- **c. LEI of Series:** 549300K3OFF3L3ODU217

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $874756406.64

**Total Liabilities:** $27023218.13

**Net Assets:** $847733188.51

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000025771 | 4.62%                | 12.36%               | 0.03%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-18633.57               | $26634794.23                               |
| Month 2  | $2441109.72              | $73708215.36                               |
| Month 3  | $200077.35               | $726984.64                                 |

### Schedule of Portfolio Investments

| Name                                                                       | Title                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Tarsus Pharmaceuticals Inc                                                 | TARSUS PHARMACEUTICALS INC                        | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     89724 | NS      | $7346601.12   | 0.87%             |  |  |  | No            |                  1 | On Loan: —       |
| INNOVIVA, INC.                                                             | INNOVIVA INC                                      | CUSIP: 45781M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    162923 | NS      | $3256830.77   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| XERIS BIOPHARMA HOLDINGS, INC.                                             | XERIS BIOPHARMA HOLDINGS INC                      | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    381596 | NS      | $2995528.60   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                                                | ARVINAS INC                                       | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    147705 | NS      | $1751781.30   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | CUSIP: 066922519<br>LEI: N/A                  | Long             | STIV             | RF                | US        |  26674349 | NS      | $26687686.39  | 3.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                                                   | ENLIVEN THERAPEUTICS INC                          | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    102366 | NS      | $1576436.40   | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| LENZ Therapeutics Inc                                                      | LENZ THERAPEUTICS INC                             | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50373 | NS      | $805968.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: —       |
| ORGANON & CO.                                                              | ORGANON CO                                        | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    597305 | NS      | $4282676.85   | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                                                           | NUVATION BIO INC                                  | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    551356 | NS      | $4940149.76   | 0.58%             |  |  |  | No            |                  1 | On Loan: —       |
| BRISTOL-MYERS SQUIBB COMPANY                                               | BRISTOL MYERS SQUIBB CO                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    727215 | NS      | $39225977.10  | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI PHARMACEUTICALS, INC.                                                  | ANI PHARMACEUTICALS INC                           | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     41241 | NS      | $3255564.54   | 0.38%             |  |  |  | No            |                  1 | On Loan: —       |
| PFIZER INC.                                                                | PFIZER INC                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   1444557 | NS      | $35969469.30  | 4.24%             |  |  |  | No            |                  1 | On Loan: No      |
| MERCK & CO., INC.                                                          | MERCK CO INC                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    381486 | NS      | $40155216.36  | 4.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine (MindMed) Inc                                                | MIND MEDICINE MINDMED INC                         | CUSIP: 60255C885<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    226554 | NS      | $3033558.06   | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| ROYALTY PHARMA PLC                                                         | ROYALTY PHARMA PLC                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    863800 | NS      | $33377232.00  | 3.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc                                                 | AMYLYX PHARMACEUTICALS INC                        | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    191951 | NS      | $2318768.08   | 0.27%             |  |  |  | No            |                  1 | On Loan: —       |
| OCULAR THERAPEUTIX, INC.                                                   | OCULAR THERAPEUTIX INC                            | CUSIP: 67576A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    391577 | NS      | $4753744.78   | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| NEKTAR THERAPEUTICS                                                        | NEKTAR THERAPEUTICS                               | CUSIP: 640268306<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     46783 | NS      | $1977985.24   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| XAV HEALTH CARE MAR26                                                      | XAV HEALTH CARE MAR26                             | CUSIP: N/A<br>LEI: N/A                        | N/A              | DE               |  | US        |         4 | NC      | $-1490.93     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc                                                  | EDGEWISE THERAPEUTICS INC                         | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    170261 | NS      | $4225026.72   | 0.50%             |  |  |  | No            |                  1 | On Loan: —       |
| ELI LILLY AND COMPANY                                                      | ELI LILLY CO                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    187395 | NS      | $201389658.60 | 23.76%            |  |  |  | No            |                  1 | On Loan: No      |
| WAVE Life Sciences Ltd                                                     | WAVE LIFE SCIENCES LTD                            | CUSIP: Y95308105<br>LEI: N/A                  | Long             | EC               | CORP              | SG        |    332094 | NS      | $5645598.00   | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| CORCEPT THERAPEUTICS INCORPORATED                                          | CORCEPT THERAPEUTICS INC                          | CUSIP: 218352102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    215084 | NS      | $7484923.20   | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY                                | JAZZ PHARMACEUTICALS PLC                          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |    139606 | NS      | $23733020.00  | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| PHIBRO ANIMAL HEALTH CORPORATION                                           | PHIBRO ANIMAL HEALTH CORP                         | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     47027 | NS      | $1756928.72   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY                              | AVADEL PHARMACEUTICALS PLC                        | CUSIP: G29687103<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |    224365 | NS      | $4835065.75   | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| CORMEDIX INC.                                                              | CORMEDIX INC                                      | CUSIP: 21900C308<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    168518 | NS      | $1959864.34   | 0.23%             |  |  |  | No            |                  1 | On Loan: —       |
| THERAVANCE BIOPHARMA, INC.                                                 | THERAVANCE BIOPHARMA INC                          | CUSIP: G8807B106<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |     85071 | NS      | $1591678.41   | 0.19%             |  |  |  | No            |                  1 | On Loan: —       |
| Liquidia Corp                                                              | LIQUIDIA CORP                                     | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    157897 | NS      | $5445867.53   | 0.64%             |  |  |  | No            |                  1 | On Loan: —       |
| Septerna Inc                                                               | SEPTERNA INC                                      | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     52517 | NS      | $1464173.96   | 0.17%             |  |  |  | No            |                  1 | On Loan: —       |
| ELANCO ANIMAL HEALTH INCORPORATED                                          | ELANCO ANIMAL HEALTH INC                          | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |   1141532 | NS      | $25832869.16  | 3.05%             |  |  |  | No            |                  1 | On Loan: —       |
| Rapport Therapeutics Inc                                                   | RAPPORT THERAPEUTICS INC                          | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     65768 | NS      | $1995401.12   | 0.24%             |  |  |  | No            |                  1 | On Loan: —       |
| PACIRA BIOSCIENCES, INC.                                                   | PACIRA BIOSCIENCES INC                            | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     98941 | NS      | $2560593.08   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| HARMONY BIOSCIENCES HOLDINGS, INC.                                         | HARMONY BIOSCIENCES HOLDINGS INC                  | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     91305 | NS      | $3416633.10   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| EYEPOINT, INC.                                                             | EYEPOINT INC                                      | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |    178501 | NS      | $3261213.27   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                                                                 | EVOLUS INC                                        | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |    149074 | NS      | $991342.10    | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| AXSOME THERAPEUTICS, INC.                                                  | AXSOME THERAPEUTICS INC                           | CUSIP: 05464T104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     97291 | NS      | $17769228.24  | 2.10%             |  |  |  | No            |                  1 | On Loan: No      |
| LIGAND PHARMACEUTICALS INCORPORATED                                        | LIGAND PHARMACEUTICALS                            | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     45219 | NS      | $8549556.33   | 1.01%             |  |  |  | No            |                  1 | On Loan: —       |
| HARROW, INC.                                                               | HARROW INC                                        | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     75732 | NS      | $3710868.00   | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares      | BLACKROCK CASH FUNDS TREASURY                     | CUSIP: 066922477<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    442988 | NS      | $442988.27    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| JOHNSON & JOHNSON                                                          | JOHNSON JOHNSON                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    901537 | NS      | $186573082.15 | 22.01%            |  |  |  | No            |                  1 | On Loan: No      |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY                                     | PERRIGO CO PLC                                    | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    315889 | NS      | $4397174.88   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                                              | CRINETICS PHARMACEUTICALS INC                     | CUSIP: 22663K107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    218012 | NS      | $10148458.60  | 1.20%             |  |  |  | No            |                  1 | On Loan: —       |
| Terns Pharmaceuticals Inc                                                  | TERNS PHARMACEUTICALS INC                         | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |    197876 | NS      | $7994190.40   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| AMPHASTAR PHARMACEUTICALS INC                                              | AMPHASTAR PHARMACEUTICALS INC                     | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     81375 | NS      | $2179222.50   | 0.26%             |  |  |  | No            |                  1 | On Loan: —       |
| VIATRIS INC.                                                               | VIATRIS INC                                       | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |   2646167 | NS      | $32944779.15  | 3.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics Inc                                                      | MAZE THERAPEUTICS INC                             | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48692 | NS      | $2017309.56   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences Inc                                                        | MBX BIOSCIENCES INC                               | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     57829 | NS      | $1823926.66   | 0.22%             |  |  |  | No            |                  1 | On Loan: —       |
| OMEROS CORPORATION                                                         | OMEROS CORP                                       | CUSIP: 682143102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    163057 | NS      | $2800503.98   | 0.33%             |  |  |  | No            |                  1 | On Loan: —       |
| Ventyx Biosciences Inc                                                     | VENTYX BIOSCIENCES INC                            | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    147703 | NS      | $1333758.09   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| SUPERNUS PHARMACEUTICALS, INC.                                             | SUPERNUS PHARMACEUTICALS INC                      | CUSIP: 868459108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    131735 | NS      | $6547229.50   | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| PRESTIGE CONSUMER HEALTHCARE INC.                                          | PRESTIGE CONSUMER HEALTH                          | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110472 | NS      | $6815017.68   | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| ZOETIS INC.                                                                | ZOETIS INC                                        | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    315412 | NS      | $39685137.84  | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| AMNEAL PHARMACEUTICALS, INC.                                               | AMNEAL PHARMACEUTICALS INC                        | CUSIP: 03168L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    389744 | NS      | $4910774.40   | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc                                                     | TREVI THERAPEUTICS INC                            | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    238204 | NS      | $2982314.08   | 0.35%             |  |  |  | No            |                  1 | On Loan: —       |
| PHATHOM PHARMACEUTICALS, INC.                                              | PHATHOM PHARMACEUTICALS INC                       | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    104364 | NS      | $1731398.76   | 0.20%             |  |  |  | No            |                  1 | On Loan: —       |
| INDIVIOR PLC                                                               | INDIVIOR PLC                                      | CUSIP: G4766E116<br>LEI: 213800V3NCQTY7IED471 | Long             | EC               | CORP              | GB        |    286849 | NS      | $10292142.12  | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical, Inc.                                             | COLLEGIUM PHARMACEUTICAL INC                      | CUSIP: 19459J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     72626 | NS      | $3362583.80   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-01-30

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer